Roche Diagnostics in the UK and Ireland work with trade bodies who represent manufacturers and other organisations involved in the research and development of in-vitro diagnostics. In the United Kingdom, our industry is represented by the British In-vitro Diagnostic Association (BIVDA).

As well as providing a range of support services for its members, BIVDA pursues a strategy of raising the awareness of the clinical and cost utility of diagnostics in the provision of effective healthcare in the UK.

In Ireland, we are represented by IMSTA, which is the representative body for medtech suppliers in Ireland. Member companies include the full spectrum of medical technology supply and service companies from Small and Medium-sized Enterprises (SME) to multi-national corporations, many of whom have R&D and/or manufacturing facilities in Ireland.

IMSTA provides a forum for the development and advocacy of policies that support innovation in medical technology to address patients’ healthcare needs.

Members of trade bodies are governed by a Code of Conduct ensuring members’ business practice is an integral part of the association.

Our ultimate focus is on supporting the UK’s health service to improve health outcomes and we will continue to work with our partners in industry and the NHS on that goal.   

 

Roche Products, a manufacturer of medicines across a range of disease areas, works closely with partners in industry in the UK. We are a member of a number of industry bodies including the Association of the British Pharmaceutical Industry (ABPI), the European Medicines Group (EMG) and the Confederation of British Industries (CBI). 

 

We play an active role within these groups on key issues, not least around improving patient access to innovative, new medicines and supporting our partners in the NHS to deliver high quality care. Roche also works with our trade bodies to help sustain and enhance the wider life science sector in the UK. Members of the ABPI are governed by the ABPI Code of Practice for the Pharmaceutical Industry. This code extends beyond the extensive laws and regulations which govern our industry to ensure that we work professionally, with integrity and respect for those we work with and are transparent about that work and how we engage with others.

Our ultimate focus is on supporting the UK’s health service to improve health outcomes and we will continue to work with our partners in industry and the NHS on that goal. 

Reference

  1. PwC UK, ‘The Economic contribution of the UK Life Sciences industry’, 2017)

 

RXUKNONP00527e

Date of preparation: October 2018